Heart Attacks Diagnostics Market Trends
- Reports Overview
- Table Of Content
- Research Methodology
Heart Attack Diagnostics Market Size, Share & Trends Analysis Report By Test (Electrocardiogram, Blood Test), By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2024 – 2030
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
- Chapter 3. Heart Attack Diagnostics Market Variables, Trends, & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.2. Market Size and Growth Prospects (USD Billion)
- 3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
- 3.4. Heart Attack Diagnostics Market Analysis Tools
- 3.4.1. Porter’s Analysis
- 3.4.1.1. Bargaining power of the suppliers
- 3.4.1.2. Bargaining power of the buyers
- 3.4.1.3. Threats of substitution
- 3.4.1.4. Threats from new entrants
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Economic and Social landscape
- 3.4.2.3. Technological landscape
- 3.4.2.4. Environmental landscape
- 3.4.2.5. Legal landscape
- 3.4.1. Porter’s Analysis
- Chapter 4. Heart Attack Diagnostics Market: Test Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Heart Attack Diagnostics Market: Test Movement Analysis, 2023 & 2030 (USD Billion)
- 4.3. Electrocardiogram
- 4.3.1. Electrocardiogram Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
- 4.4. Blood Test
- 4.4.1. Blood Test Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
- 4.4.1.1. Troponin
- 4.4.1.1.1. Troponin Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
- 4.4.1.2. CK-MB
- 4.4.1.2.1. CK-MB Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
- 4.4.1.1. Troponin
- 4.4.1. Blood Test Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
- 4.5. Others
- 4.5.1. Others Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
- Chapter 5. Heart Attack Diagnostics Market: End Use Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Heart Attack Diagnostics Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
- 5.3. Hospitals
- 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
- 5.4. Ambulatory Surgical Centers
- 5.4.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
- 5.5. Others
- 5.5.1. Others Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
- Chapter 6. Heart Attack Diagnostics Market: Regional Estimates & Trend Analysis
- 6.1. Market Share By Region, 2023 & 2030
- 6.2. North America
- 6.2.1. North America Estimates
- 6.2.2. U.S.
- 6.2.2.1. U.S. Market Forecasts
- 6.2.3. Canada
- 6.2.3.1. Canada Market Forecasts
- 6.2.4. Mexico
- 6.2.4.1. Mexico Market Forecasts
- Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis
- 7.2. Company Categorization
- 7.3. Company Heat Map Analysis
- 7.4. Company Profiles
- 7.4.1. GE Healthcare
- 7.4.2. Hitachi Corporation
- 7.4.3. Koninklijke Philips NV
- 7.4.4. Midmark Corporation
- 7.4.5. F Hoffmann-La Roche Ltd
- 7.4.6. Schiller AG
- 7.4.7. Siemens Healthineers
- 7.4.8. Toshiba Corporation
- 7.4.9. Welch Allyn Inc
- 7.4.10. AstraZeneca PLC
Research Methodology
Grand View Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. The company utilizes a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. In Addition, a recurring theme prevalent across all our research reports is data triangulation that looks market from three different perspectives. Critical elements of methodology employed for all our studies include:
Preliminary data mining
Raw market data is obtained and collated on a broad front. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. For comprehensive understanding of the market, it is essential to understand the complete value chain and in order to facilitate this; we collect data from raw material suppliers, distributors as well as buyers.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered. As a result, the material developed contains a wide range of original data that is then further cross-validated and authenticated with published sources.
Statistical model
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise.
Econometric models are generally used for short-term forecasting, while technological market models are used for long-term forecasting. These are based on an amalgamation of technology landscape, regulatory frameworks, economic outlook and business principles. A bottom-up approach to market estimation is preferred, with key regional markets analyzed as separate entities and integration of data to obtain global estimates. This is critical for a deep understanding of the industry as well as ensuring minimal errors. Some of the parameters considered for forecasting include:
• Market drivers and restrains, along with their current
and expected impact
• Raw material scenario and supply v/s price trends
• Regulatory scenario and expected developments
• Current capacity and
expected capacity additions up to 2030
We assign weights to these parameters and quantify their market impact using weighted average analysis, to derive an expected market growth rate.
Primary validation
This is the final step in estimating and forecasting for our reports. Exhaustive primary interviews are conducted, on face to face as well as over the phone to validate our findings and assumptions used to obtain them. Interviewees are approached from leading companies across the value chain including suppliers, technology providers, domain experts and buyers so as to ensure a holistic and unbiased picture of the market. These interviews are conducted across the globe, with language barriers overcome with the aid of local staff and interpreters. Primary interviews not only help in data validation, but also provide critical insights into the market, current business scenario and future expectations and enhance the quality of our reports. All our estimates and forecast are verified through exhaustive primary research with Key Industry Participants (KIPs) which typically include:
• Market leading companies
• Raw
material suppliers
• Product distributors
• Buyers
The key objectives of primary research are as follows:
• To validate our data in terms of accuracy and
acceptability
• To gain an insight in to the current market and future
expectations
Data Collection Matrix
|
Perspective |
Primary research |
Secondary research |
|
Supply side |
|
|
|
Demand side |
|
|
Industry Analysis
Matrix
|
Qualitative analysis |
Quantitative analysis |
|
|
The global heart attack diagnostics market size was valued at USD 10.75 billion in 2023 and is projected to grow at a CAGR of 8.2% from 2024 to 2030. Unhealthy lifestyle choices, such as poor dietary habits, tobacco smoking, high body mass index, sedentary lifestyles, and the prevalence of chronic diseases such as diabetes and hypertension, are the primary risk factors contributing to the development of heart attacks in individuals.
The occurrence of a heart attack, or myocardial infarction, arises when specific regions of the heart muscle experience a lack of oxygen supply. This situation occurs due to the obstruction of blood flow to the heart muscle.
The COVID-19 pandemic adversely affected diagnosis and treatment of non-communicable diseases. The pandemic caused widespread disruptions in healthcare systems worldwide. Fear of contracting COVID-19 led many people to avoid seeking medical attention for potential medical attack symptoms.
According to the World Heart Report, cardiovascular diseases continue to affect more than 500 million people across the globe. Alarmingly, these diseases claimed the lives of 20.5 million individuals in 2021, accounting for nearly a third of all deaths worldwide. This represents a substantial increase compared to the estimated 121 million deaths attributed to cardiovascular diseases (CVDs). It impacts the heart and blood vessels, and their occurrence can be attributed to a combination of socio-economic, metabolic, behavioral, and environmental risk factors. These risk factors encompass high blood pressure, an unhealthy diet, elevated cholesterol levels, diabetes, air pollution, obesity, tobacco usage, kidney disease, physical inactivity, excessive alcohol consumption, and stress.
Test Insights
In 2023, the blood tests segment emerged as the market leader, capturing the largest revenue share of 54.1%. One of the key factors driving the demand for blood tests in heart attack diagnostics is Troponin T, a protein found in heart muscle. Health care professionals utilize high-sensitivity troponin T tests to diagnose heart attacks and assess the risk of heart disease. Interestingly, even individuals without symptoms can have an increased level of troponin T, indicating a higher risk of heart disease. Other contributing factors include elevated cholesterol levels, the growing consumption of alcohol and tobacco, and the prevalence of unhealthy lifestyles among people.
The electrocardiogram segment is anticipated to exhibit a CAGR of 7.2% from 2024 to 2030, owing to factors such as the growing elderly population, unhealthy lifestyles, and the increase in tobacco and alcohol use. Additionally, the progress in technology and the heightened emphasis on healthcare in emerging nations such as India and China could create additional investment and research prospects, potentially impacting the worldwide ECG market.
The Troponin segment dominated the blood tests market and accounted for a share of 62.5% in 2023. Troponin T, a protein present in the heart muscle, is crucial in diagnosing heart attacks through a high-sensitivity troponin T test. This test is usually conducted when there are suspicions of heart muscle damage or during critical medical situations like heart attacks. Factors that can contribute to increased troponin levels include rapid heartbeat, high blood pressure in the lungs, and blockages in lung arteries due to blood clots, fat, or tumor cells.
The CK-MB (creatine kinase-myoglobin binding) segment in the blood tests category is expected to grow rapidly at a CAGR of 9.6% over the forecast period. The CK-MB test is utilized to determine the level of creatine kinase in the bloodstream. This specific enzyme is predominantly found in the heart, with minor amounts also present in the skeletal muscles.
End-use Insights
The hospital segment accounted for a share of 21.5% in 2023 primarily attributed to the extensive surgical procedures carried out in hospital settings and the widespread penetration of hospitals globally. Each year, over 290,000 adults in the U.S. experience in-hospital cardiac arrests.
The ambulatory segment is expected to grow at a CAGR of 10.6% during forecast period. There is an increasing emphasis on expediting and enhancing the convenience of diagnosis, especially for non-critical cases. Moreover, the progress in medical technology is driving the creation of portable and user-friendly diagnostic tools.
Regional Insights
North America emerged as the largest global heart attack diagnostics market, with a 38.5% share in 2023 pertaining to the rise of cardiovascular cases in Canada and the U.S. Other factors that play a key role in market development include advanced healthcare infrastructure and increased investments in innovation.
U.S. Heart Attack Diagnostics Market Trends
The U.S. heart attack diagnostics market is expected to witness a significant growth of CAGR 8.2% during the forecast period. Recent research conducted by the U.S. Centers for Disease Control (CDC) indicates that every 40 seconds, a person in the U.S. undergoes a heart attack, making it the most expensive medical treatment in American healthcare facilities. The American Heart Association forecasts that around 45% of the U.S. population will be impacted by heart diseases by 2035, largely due to factors such as obesity, smoking, and sedentary lifestyles, all of which can increase the risk of heart attacks and other cardiovascular complications.
Europe Heart Attack Diagnostics Market Trends
The Europe heart attack diagnostics market, with a valuation of 3.1 billion, is expected to witness a growth rate of 7.4% during the forecast period from 2024 to 2030. The increase in patients with coronary artery disease and peripheral artery diseases has contributed to this growth. The European Union reported on March 21, 2022, that cardiovascular attacks were a leading cause of death in the EU. Additionally, advancements in technology are incorporating portability features into testing devices, which is driving market revenue growth.
The heart attack diagnostics market in UK is projected to witness steady growth rate in forecast period owing to an ageing and growing population and improved survival rates. Furthermore, the country’s development in research and technology is pushing the market.
Germany heat attack diagnostics market is expected to experience growth in the coming years. Germany is one of the top countries in terms of mortality rates from heart attacks. Cardiovascular diseases are the leading cause of death in the Germany. In addition, they are associated with significant health consequences for the individual and result in high medical costs for society.
Asia Pacific Heart Attack Diagnostics Market Trends
The heart attack diagnostics market in Asia Pacific is projected to witness a steady CAGR of 10.0% during the forecast period. Few regions experience a heavy burden of heart diseases, due to a large patient population in countries such as India and China.
The China heart attack diagnostics market is expected to witness a strong growth rate during the forecast period, 2024-2030. A recent report from Biospectrum reveals that China has a staggering population of around 290 million individuals affected by cardiovascular disease (CVD). CVD, encompassing stroke and ischemic heart disease (including heart attacks), stands as the primary cause of mortality in China, responsible for nearly two-fifths of all deaths. Notably, ischemic heart disease is rapidly emerging as the leading cause of premature death in the country.
Key Heart Attack Diagnostics Company Insights
The surge in competition is driving rapid technological progress, prompting companies to enhance their products through extensive research and development efforts. Leading companies are adopting various strategic approaches like mergers & acquisitions, partnerships, and new product introductions to increase their market presence.
Key Heart Attack Diagnostics Companies:
The following are the leading companies in the heart attack diagnostics market. These companies collectively hold the largest market share and dictate industry trends.
- GE Healthcare
- Hitachi Corporation
- Koninklijke Philips NV
- Midmark Corporation
- F Hoffmann-La Roche Ltd
- Schiller AG
- Siemens Healthineers
- Toshiba Corporation
- Welch Allyn Inc
- Astrazenca PLC
Recent Developments
In April 2024, GE Healthcare introduced Caption AI on Vscan Air SL to expand cardiac care access by allowing more clinicians/medical professional capture diagnostic-quality cardiac images.
In June 2024, Philips announced the launch of Philips Cardiac Workstation aims to transform diagnostic cardiology with introduction of new Cardiac Workstation, to enhance cardiology patients care and accelerate clinical decision making in Middle East and Africa (MEA) and Europe
Key Heart Attack Diagnostics Companies:
| Report Attribute | Details |
| Market size value in 2024 | USD 11.53 billion |
| Revenue forecast in 2030 | USD 18.52 billion |
| Growth rate | CAGR of 8.2% from 2024 to 2030 |
| Base year for estimation | 2023 |
| Historical data | 2018 – 2022 |
| Forecast period | 2024 – 2030 |
| Quantitative units | Revenue in USD billion and CAGR from 2024 to 2030 |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | Test, end use, region |
| Regional scope | North America, Europe, Asia Pacific, Latin America, MEA |
| Country scope | U.S., Canada, Mexico, Germany, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, Japan, China, India, Australia, South Korea, Thailand Brazil, Argentina, South Africa, Saudi Arabia, UAE and Kuwait. |
| Key companies profiled | GE Healthcare; Hitachi Corporation; Koninklijke Philips NV; Midmark Corporation; F Hoffmann-La Roche Ltd; Schiller AG; Siemens Healthineers; Toshiba Corporation; Welch Allyn Inc; Astrazenca PLC |
| Customization scope | Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
Global Heart Attack Diagnostics Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global heart attack diagnostics market report based on test, end use, and region:
Kuwait
Test Outlook (Revenue, USD Billion, 2018 – 2030)
Electrocardiogram
Blood Test
Troponin
CK-MB
Others
End-use Outlook (Revenue, USD Billion, 2018 – 2030)
Hospitals
Ambulatory Surgical Centers
Others
Regional Outlook (Revenue, USD Billion, 2018 – 2030)
Country List by Region
ASK FOR SAMPLE
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get A SampleCountries by Region
| Region | Countries |
|---|---|
| North America | U.S. Canada, Mexico |
| Europe | UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway |
| Asia Pacific | Japan, China, India, Australia, Thailand, South Korea |
| Latin America | Brazil, Argentina |
| Middle East & Africa | South Africa, Saudi Arabia, UAE |
